Skip to content

Cost of care shown to be primary barrier to adherence in African study

High rates of AIDS and death in first year of life argue for universal ART for kids with HIV

Brazil wins 75% discount on new HIV drug

How will AZT and nevirapine use for MTCT affect future treatment? Two studies provide clues

Total lymphocyte count predicts risk of death in children

Second English HIV transmission prosecution rings alarm bells

NNRTI-based HAART associated with quicker CD4 cell gains than PI-based therapy

Cheap multivitamin pill increases survival in those with low CD4 counts

Vaxgen announces second phase III trial failure in its AIDSVAX programme